Omnicell Inc: (NASD: OMCL)
$18.81
0.15 (0.80%)
Volume 118,422
May 17 04:00 PM ET
Zacks Rank: 2-Buy 
| #2 |
Comparison to Industry
Industry / Sector Report
Industry: MEDICAL INFO SYSTEMS
Zacks Industry Rank: 
Rank in Industry:
Recommendations and Estimates
| Company | Industry | SP500 | |
|---|---|---|---|
| Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.85 | 9.99 |
| Current Quarter Estimate | 0.21 | 0.18 | 25.88 |
| Year Ago Quarter Estimate | 0.13 | 0.14 | 24.24 |
| Next Quarter Estimate | 0.24 | 0.20 | 26.63 |
| Next Year Estimate | NA | 0.16 | 25.43 |
Growth Rates
| Company | Industry | SP500 | |
|---|---|---|---|
| This Year (40) | 40.00 | 3.60 | 11.40 |
| Next Year (NA) | NA | 22.70 | 6.50 |
| Last 5 Years | 4.30 | 15.40 | 5.70 |
| Next 5 Years | 16.70 | 17.90 | NA |
Financials
| Company | Industry | ||
|---|---|---|---|
| Price/Earnings (TTM) | 30.84 | 74.98 | |
| Price/Book (MRQ) | 2.03 | 3.74 | |
| Price/Cash Flow (MRFY) | 18.40 | 18.08 | |
| Dividend Yield | 0.00% | 0.00% | |
| Net Profit Margin (TTM) | 5.10% | 3.77% | |
| Return on Equity (TTM) | 6.92% | 7.07% | |
| Debt to Equity (MRQ) | 0.00 | 2.26 |
MRQ = Most Recent Quarter TTM = Trailing Twelve Months MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.
